Discover the official application of the Latin American Multiple Myeloma Study Group (GELAMM), designed to provide comprehensive support in the clinical practice of the treatment and monitoring of patients with Multiple Myeloma.

Aimed primarily at health professionals, the app facilitates access to the protocols indicated according to the patient's characteristics, progression and review criteria, reference guides, scores, active ingredients, and other information relevant to the community of hematologists in Latin America.

In addition, patients linked to Multiple Myeloma will be able to access basic information about the disease, available treatments and specialized institutions in various countries in the region.

An essential tool to improve the care and management of Multiple Myeloma, created by GELAMM for doctors and patients.